Retatrutide (10mg–40mg)

Retatrutide (10mg–40mg)

Research information

Description & mechanism

Retatrutide is a synthetic peptide and triple agonist of the GLP-1, GIP, and glucagon receptors, engineered to probe combined incretin and glucagon-receptor activity. It is used in research to study energy metabolism, glucose homeostasis, and adipose signalling in experimental models.

Applications in research

  • Multi-receptor (GLP-1/GIP/glucagon) activation and selectivity profiling
  • Glucose regulation and insulin-secretion studies in vitro
  • Metabolic and energy-expenditure signalling in preclinical models

Specifications

Molecular weight4731.3 g/mol
CAS number2381089-83-2
Purity / qualityThe COA for your batch is available on request.
FormLyophilized solid
Storage2–8 °C, desiccated, protected from light
Pack sizes10 mg, 20 mg, 40 mg

Handling, reconstitution & storage

Reconstitute the lyophilized solid in sterile water or bacteriostatic diluent to the desired working concentration; mix by gentle inversion and avoid vigorous agitation or repeated freeze-thaw. Sterile-filter (0.22 µm) if aseptic use is required, aliquot into single-use volumes, and store reconstituted material frozen at -20 °C.

Batch certificates

The COA for your batch is available on request. Contact us with the batch ID from your vial label.

Precautions & notes

For in-vitro research and laboratory use only. Bodily introduction of any kind into humans or animals is strictly forbidden. Handle as a bioactive substance using appropriate PPE and consult the safety data sheet. Note: retatrutide is an investigational peptide with no approved human use.

References

  1. Jastreboff et al. 2023 (PMID 37366315)